B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres

BACKGROUND: The dismal survival of glioblastoma (GBM) patients urgently calls for the development of new treatments. Chimeric antigen receptor T (CAR-T) cells are an attractive strategy, but preclinical and clinical studies in GBM have shown that heterogeneous expression of the antigens targeted so...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehama, Dean, Di Ianni, Natalia, Musio, Silvia, Du, Hongwei, Patané, Monica, Pollo, Bianca, Finocchiaro, Gaetano, Park, James J.H., Dunn, Denise E., Edwards, Drake S., Damrauer, Jeffrey S., Hudson, Hannah, Floyd, Scott R., Ferrone, Soldano, Savoldo, Barbara, Pellegatta, Serena, Dotti, Gianpietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796553/
https://www.ncbi.nlm.nih.gov/pubmed/31466914
http://dx.doi.org/10.1016/j.ebiom.2019.08.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796553/
https://www.ncbi.nlm.nih.gov/pubmed/31466914
http://dx.doi.org/10.1016/j.ebiom.2019.08.030

Ejemplares similares